Eton Pharmaceuticals, Inc. — Investor Relations & Filings
Filings indexed
358
across all filing types
Latest filing
2026-05-19
Regulatory Filings
Country
US
United States of America
Listing
US
ETON
Eton Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing treatments for rare diseases. The company's strategy involves sourcing, acquiring, and developing therapies to serve small, underserved patient populations. Eton manages the complete drug development lifecycle, from navigating clinical trials and the regulatory approval process to bringing the final products to market. It actively seeks meaningful therapies from a global network of partners to build a diversified portfolio of treatments.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2026-05-19 | English | |
| FORM 10-Q | 2026-05-14 | English | |
| FORM 8-K | 2026-05-14 | English | |
| 8-K - Eton Pharmaceuticals, Inc. (0001710340) (Filer) | 2026-04-27 | English | |
| 8-K - Eton Pharmaceuticals, Inc. (0001710340) (Filer) | 2026-04-16 | English | |
| 10-K - Eton Pharmaceuticals, Inc. (0001710340) (Filer) | 2026-03-19 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46558152 | FORM 8-K | 2026-05-19 | English | ||
| 46296974 | FORM 10-Q | 2026-05-14 | English | ||
| 46344643 | FORM 8-K | 2026-05-14 | English | ||
| 37413232 | 8-K - Eton Pharmaceuticals, Inc. (0001710340) (Filer) | 2026-04-27 | English | ||
| 34646791 | 8-K - Eton Pharmaceuticals, Inc. (0001710340) (Filer) | 2026-04-16 | English | ||
| 32989295 | 10-K - Eton Pharmaceuticals, Inc. (0001710340) (Filer) | 2026-03-19 | English | ||
| 32989272 | 8-K - Eton Pharmaceuticals, Inc. (0001710340) (Filer) | 2026-03-19 | English | ||
| 32897095 | 8-K - ETON PHARMACEUTICALS, INC. (0001710340) (Filer) | 2026-03-02 | English | ||
| 32897096 | 8-K - ETON PHARMACEUTICALS, INC. (0001710340) (Filer) | 2026-02-25 | English | ||
| 31417006 | 4 Filing | 2026-02-05 | English | ||
| 31417071 | 8-K Filing | 2026-02-02 | English | ||
| 13045755 | FORM 4 | 2026-01-15 | English | ||
| 13045756 | FORM 4 | 2026-01-15 | English | ||
| 13045757 | FORM 4 | 2026-01-15 | English | ||
| 13045758 | FORM 4 | 2026-01-15 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
Eton Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32663/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32663 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32663 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32663 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32663}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Eton Pharmaceuticals, Inc. (id: 32663)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.